This application is for further studies of EEG sleep in schizophrenia. The investigator's data indicate that reductions in slow wave sleep (SWS) in schizophrenia are present early in the disorder and persist during later phases of illness. He also finds that decreased SWS in schizophrenia correlates with negative symptoms, attentional impairment, relatively poor outcome and abnormal brain metabolism as evidenced by 31Phosphorous MRS (31P MRS) studies. MR studies have also revealed significant volume deficits in cortical gray matter, as well as altered membrane and energy metabolism in the prefrontal cortex in these patients. The presence of the observed alterations early in illness, the lack of a relationship with illness duration and their persistence suggest that they may be related to neurodevelopmental abnormalities. The investigator therefore hypothesizes that abnormal SWS in schizophrenia is related to developmentally-mediated pathophysiology of the association cortex and the thalamus. The overall goal of this continuation grant application is to examine EEG sleep parameters (specifically SWS), in conjunction with brain structural and metabolic data, in order to address the pathophysiological heterogeneity in schizophrenia. This application aims: 1) to confirm in a first-episode treatment-naive population, our findings of decreased SWS and metabolic and structural alterations in the association cortex and thalamus; and 2) to examine whether decreased SWS is associated with abnormal structure and metabolism in the association cortex and thalamus, with negative symptoms, cognitive and neurological impairment, poor premorbid functioning, and poor outcome in schizophrenia. The investigator also wishes to obtain preliminary data on: 1) whether schizophrenia patients have a defect in recovery of SWS, but not rapid eye movement (REM) sleep after sleep deprivation; and 2) whether decreased SWS and other proposed alterations in corticothalamic structure and metabolism are more frequently seen in """"""""high-risk"""""""" offspring of schizophrenic parents. To address these aims, he proposes to examine 60 drug-free first-episode schizophrenic patients, 30 """"""""high-risk"""""""" offspring of schizophrenic parents and 90 matched healthy controls and conduct sleep EEG, 31P MRS and MRI studies, neurological, neuropsychological and clinical evaluations. The hypotheses in this study, if confirmed, will contribute to progress toward a neurodevelopmental classification of schizophrenia as well as toward a better understanding of vulnerability to this enigmatic illness.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH045203-08
Application #
2890409
Study Section
Clinical Neuroscience and Biological Psychopathology Review Committee (CNBP)
Program Officer
Foote, Stephen L
Project Start
1991-04-01
Project End
2001-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Francis, Alan N; Bhojraj, Tejas S; Prasad, Konasale M et al. (2013) Alterations in the cerebral white matter of genetic high risk offspring of patients with schizophrenia spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 40:187-92
Yao, Jeffrey K; Condray, Ruth; Dougherty Jr, George G et al. (2012) Associations between purine metabolites and clinical symptoms in schizophrenia. PLoS One 7:e42165
Yao, Jeffrey K; Keshavan, Matcheri S (2011) Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal 15:2011-35
Keshavan, Matcheri S; Montrose, Debra M; Miewald, Jean M et al. (2011) Sleep correlates of cognition in early course psychotic disorders. Schizophr Res 131:231-4
Condray, Ruth; Dougherty Jr, George G; Keshavan, Matcheri S et al. (2011) 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol 14:756-67
Francis, Alan N; Bhojraj, Tejas S; Prasad, Konasale M et al. (2011) Abnormalities of the corpus callosum in non-psychotic high-risk offspring of schizophrenia patients. Psychiatry Res 191:9-15
Reddy, R; Fleet-Michaliszyn, S; Condray, R et al. (2011) Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study. Prostaglandins Leukot Essent Fatty Acids 84:79-83
Diwadkar, Vaibhav A; Goradia, Dhruman; Hosanagar, Avinash et al. (2011) Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers. Prog Neuropsychopharmacol Biol Psychiatry 35:1349-54
Yao, Jeffrey K; Dougherty Jr, George G; Reddy, Ravinder D et al. (2010) Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naive patients with schizophrenia. PLoS One 5:e9508
Yao, J K; Dougherty Jr, G G; Reddy, R D et al. (2010) Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry 15:938-53

Showing the most recent 10 out of 53 publications